OFIX - Earnings call transcript Q2 2018

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good day, ladies and gentlemen, and welcome to the Orthofix Second Quarter 2018 Earnings Results Conference. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference to your host, Mr. Business Investor of Director Quick, Development Relations. and Mark the floor yours. is Sir,

Mark Quick

everyone. and call. the operator you, Welcome good earnings Thank XXXX afternoon, to quarter Orthofix second

me it I’ll start Chief our President Safe and today and the Brad. with Financial Officer, then statements, pass Chief Rice. Brad Mason; to Joining and Doug Officer, Harbor on over call Executive are

assurance our XX, statements, XXXX. such as guidance those statements reliance on uncertainties. All and we provide obligation this During contained the of fact August statements make plans, matters involve statements historical that beliefs about call, of or earnings call today, place not Investors forward-looking we’ll goals statements. beliefs, be risks do forward-looking cautioned including to are there’s any and such strategies, in based undue are and forward-looking revise other statements statements not update today’s no to expectations we or making on that any undertake will than as We any are forward-looking our such occur. on statements The forward-looking objectives. expectations,

Some in forward-looking make made the the us the actual be the results factors we in XXXX, additional disclosed on risks include year-ended our Factors future. as statements Form call XX, the XX-K heading filings by December from different Risk that under could as SEC materially cause the to for well

my in office If you Texas. Orthofix contact of at please copies need documents, these Lewisville,

quarter results. announcing may for review non-GAAP matters refer order press this measures. release properly and to to supplement long-term Brad. XXXX of trends, financial point, non-GAAP In GAAP short-term turn to addition, our call, GAAP. determined to to U.S. these over At wish these Please call to our with measures measures accordance believe financial results We understand on I'll the in U.S. reconciliations today’s to today's second in that a refer investors financial as financial we’ll our various financial

Brad Mason

everyone. afternoon, good and Mark, Thanks,

start realigned XXXX addition wins future and results I'll Kinetics our our XX% synergy up giving and Doug taking the of big operationally, of of with was the the second of integration inventory, summary XX; by I quarter the across four usual, spine Curacao financial Spinal in for company our reduced Delaware, which we unit with As year. or business remainder July for businesses; from we structure of will position follow to that the our today. prior Kinetics; which the Starting the of move million growth after over accelerate discuss finalized questions. realize the by corporate XXXX on before performance, quarter, excluding the the reported all inventories domicile to a completed and Spinal outlook you almost our will then acquisition opportunities $X.X

of the We little developments a each these many you minutes. positive give come. few expect of see years more on in to a for will these to benefit I color

basis margin compared the in the point of of Spinal XXXX, Kinetics, in quarter. increase. a our quarter we line XX.X%, came adjusted EBITDA highlight XX at excluding in performance. margin EBITDA XX.X% of Adjusted Another a to bottom impact QX XX.X% the When strong had was

and goal progress EBITDA show XXX two in of our We next to operating the years. each basis by reducing our achieve least our continuing points in to at expenses are pleased stated margin adjusted year of organic increasing this

now that line I few in there will the of Moving were discuss our quarter on detail. temporary sales performance, top drivers more in to shortfall to the guidance a

receipt X.X% of was The For X.X% as fee excluding in and for X.X% at including BioStim, Kinetics, rate, constant the short reported million sales the to in the the large X.X% convert reported a orders growth end of unusually net of currency. we plan representing year-over-year necessary our grew currency. to late organic and MTF Spinal quarter. of to Starting prior due and a reported This constant the million, Spinal was net period, Kinetics, year. normalized $XXX.X change with $X approximately of of over core increase sales reported X.X% quantity performance sales as documentation

typical documentation is in it open QX, to too far While normal the to exceeded orders. in get we be some period late processed, ending our period

and would we early was orders July, to this revenue. as However, then the in documentation processed converted were expect,

to and second see Kinetics quarter the orders, growth adjusting portfolio rate products, the Anterior for of for this for new our demand continue ending Plate increase bone remained quarter Expandable about More by SBU, ago, remain the have year-to-date, the importantly, spine confident X.X% customer in U.S. in demonstrated future sales we base very Orthofix performance BioStim X.X% excluding as of a solid, growth of X.X% anticipation growth Spinal FORZA increased trend was in In of the our growth for X.X%. reported an X.X% acquisition. months the versus by therapy we by products Cervical of Three in such business. the Spinal primarily We the second management year. Spine upward began in open period CETRA prior When Fixation driven international Kinetics, reorganization sales the year-over-year sales and Interbody. period. with sales expansion

management will the plan, a implant the this spinal change be for now As beneficial. MX Spinal we believe Kinetics Kinetics OUS term, part Spinal Long responsibility the disc. all addition have integration very in sales, of to

our was We on of the of business reported end have the line did is expected Spinal the contributed the two. which sales biologics a decrease disruption of to this $X.X net that transaction sales However, to with million period next the and of prior impact in in our the in XX for year Between compared continue Kinetics or expectations. quarter, April an X.X%. close quarter

percentage normalized occurred increased change Orthofix March, the year receives fee When this mentioned, service business by with from are being increasing by decline. volumes the offset impacted sales MTF in the previously X% a in X% this in in Biologics. reduction which the negatively X% marketing period ASP As contractual sales this for

$XX.X create biologics are believe sales implants, our but realignment quarter, have a opportunities growth still which we to will realignment Spinal in the in late underperforming a where three sales about we first in million quarter, increase Spine reported this As for management year. prior Orthofix speak therapies, Kinetics was accelerate in of will growth additional sales over I total, X% in our bone future. spine change the year. spinal including minutes, second and produced biologics in our of businesses; more one few last regions in the we a In the business particular,

were of an last that rollout the quarter. our ankle lastly, guidance; the unshipped at quarter a timing reported our currency due expected miss to several and the foreign of factors and of large in impacting of business, in sales the plan June and included X.X% $X.X the in RIVAL impact orders earlier million, rate in from increase since $XXX,XXX $XXX,XXX of net a we orders system. The decreased Fixation approximately Lastly, X%. increased an to Also, period the typical constant in Extremity the net plating delay foot gave in of currency end change compared due late sales versus to quarter-end the a

continue We delay of expect this to the year. remainder this for

shortfall However, in and strive sales the we'll extremities outlook. of overachievement the normalize open year to the feel we second we and half good do in healthy expect the very business Overall, to the long-term the period other orders core remains geographies. RIVAL with mitigate ending products about and

earnings our bottom pleased non-sales with XXXX. to to very reduction we share per inventory at and QX improvement line quarter. flat are Adjusted metrics, $X.XX on the were Moving flow cash performance, compared in

Kinetics, X.X% was over showed to second year. $XX.X EPS Adjusted $X.XX XX-month quarter, million for cash was $XX.X year. flow to improvement was in Free Excluding share over the dilution for XX.X% of compared a trailing XXXX. improvement modest Spinal a ROIC XX.X% which an prior adjusted prior million increase per the

However, Kinetics highlights plan. a balance quarter, of in I our our $XX.X period, lastly, And for ROIC XX, with priority million our integration on Spinal acquisition the and finalizing excluding of now XX.X%. June starting Spinal touch had the as few Kinetics, of executing cash will adjusted XXXX. the the execution a we top was

deal, have businesses. experience and with and completed Spinal on Kinetics Following schedule. team will Spinal the plan our to teams the that already the Orthofix proven spine members to across the us Orthofix combined addition of with of relationships be Kinetic integration close help great a all

XXXX we Additionally, Drug final Spinal process meantime, on being Kinetics Food the still planned. as Administration In is and midyear and remain with to the track approval most performing timing. continue in likely approval the business with target the

organization. spine Spinal leader We spinal Kinetics opportunities across our June, announced spine into differentiated to competencies four single realigning that global products a our our spine we biologics, core in are businesses, implants, there As and long-term further and one leverage of under and many phases particularly bone growth spine Spinal operations, believe the this therapies, all of R&D, international we've is accelerate In sales businesses the growth. interest addition surgeons agents. the disc realignment, from consolidated management, significant is Kinetics initial which to both generating already MX of our sales relevant marketing. This and are with

accelerate is growth, change be will achieved opportunities that to anticipate synergies the longer sales be leverage cost this saving of term. to we objective primary in also the Although can there

corporate Curacao approval last to to getting was from our call shareholder our success Delaware. preparing since highlight in Another for our and change domicile

of working financial to was non-GAAP to predictability has corporate to We this tax major to an cash number our process by evolve it better legal, tax Delaware a and It years, our structure. and immediate business a reducing primary beneficial the step did to finance company XX%. For U.S. from tax align from operational improve and and been which XX% this legal flexibility our incorporation had better to our change operations, the respond and our and with developments management to been domicile including capabilities, we have tax well-planned the our rate, executed global last to benefit effort flexibility Law, position move of structure in the to and long-term teams, our

Delaware-domiciled officially completed July pleased XX. We to are company very have became work on this and a

still be Nasdaq Orthofix OFIX, We traded the renamed symbol, same Inc. ticker but will Medical, now under

I improving talk the we about on progress want to Lastly, are inventory our making management.

to. that plan is in a we've expansion high and this the both in need past, to managing for inventories. and for key Despite launches achieve is year field due great made inventory growth our the committed a of mentioned I new in-house It this consignment have pace our trajectory, and the us we increasing better priority beyond. margin element of progress to As product

over inventory approach line looking some remain continue progress financial that the in positive at a faced I This shareholder very the year life unexpected in reduction ability an come. of of product bottom execution for the in areas We details. prior the has headwinds, benefit minutes over end line in from summary, Overall, everything turn Spinal quarter to will future a disciplined a the top we all opportunities noted and value taken performance that almost our many Kinetics very acquisition. ago in strategies. company XX% to to between. strong in of the call we for have had our initial through design acquired yielded excluding I’ll years holistic Doug inventory to improvement the increase although the in Doug? In confident already to our now for few

Doug Rice

everyone. afternoon, good and Brad, Thanks,

mentioned. some Our I'll net quarter providing faced validate of our especially financial and results this discuss challenges results given margin on brad the had some other into financial then expansion that our sales earnings opportunities, and details topline the our start additional by many the measures. highlights

currency. we were our fee year revenues delay slightly to As basis expectations net unexpected the currency and a Fixation quarter sales Extremity on Brad primarily as constant X.X% in in second million, for on up X.X% and quarter $XXX.X the when prior reflects XXXX. total exited MTF sales up reported the a When the and over compared adjusting Spinal the Kinetics BioStim change, to in shortfall constant certain in basis we were The noted, of quarter.

by adjustments. second addition Gross XX.X% the compared of margin in Brad initiatives, related half Spinal XXXX Kinetics value by period. most was to XX the expect this fair inventory improvement inventory acquisition-related to management increase point in see to offset driven the basis The quarter As the of of in XX.X% mentioned, prior second year was we partially the continued year. recover

our Sales XXXX expectations. and quarter For the expect of the XX% be of with were line full XX.X% in we XX.X% the flat continue to sales gross between to XXXX, second and in XX%. expenses margins quarter roughly net second sales of XXXX, and year net marketing with in of

and costs Research acquisition core to in benefits X.X% XXXX quarter, primarily Non-GAAP drivers XX% in integration share-based increase expect to Spinal year, efforts shares professional due quarter margin XXXX. quarter our and of XX.X% prior fee primarily which sales, by were addition with basis share-based to U.S. the and to and margin were year. the FDA This is gross The a the were performance reductions in the premarket GAAP expenses from up were and expense to in improvement sales The continue higher were of primarily net results. MX mostly of the net total corporate investments in was development relative our the XX.X% approval Spinal XXXX, prior-year reflects sales the up disk. of net quarter These increased was re-domicile. We over XX of which second compensation investments. strategic approximately and sales the second the costs the net which the marketing of percent expenses savings to the of return-based earlier associated primarily offset in the were the prior compensation due net treatment sales higher improvement cervical accounting grant of regulatory Kinetics and track in administrative from Kinetics X.X% cost from was spending pertaining the as related increases due the of comp. period. and up sales strategic expense date of in restructuring. of This and points the to general primary shareholder XXXX from XX.X% second of XXXX’s

came X% during to Adjusted expenses, the in net improvement back margin half these the The approximately and up between be gross we X% in year. quarter With net sales of improvement. sales XX.X% full EBITDA ongoing of and increased of spending from prior the of expect the the to for driver second from year. primary step R&D XX.X% to X% quarter margin the in XX-basis-point this year our

was expenses. also We spending. these core restructuring savings in created our G&A U.S. restructuring Offsetting cost in improvements leverage the spending. have fairly in XXXX G&A increase core R&D significant since U.S. operating in

As margin was during Brad Kinetics, basis XXX quarter points. Spinal mentioned, excluding expansion the

period before million million tax expense Now, had and of tax was turning tax, rate in as of nondeductible by XX.X% we same income This XXXX. before increase to the in quarter U.S. quarter income December. lower taxes, $X.X our the to enacted or income compared of taxes expense income higher offset the XX.X% year-over-year for income tax driven rate income or $X.X lower of tax in earnings by GAAP expenses of

potential as result volatility settlements. a GAAP of in continue acquisition will quarterly to the timing of the rate Spinal the We see as as well tax tax Kinetics audit

As from shareholder was Brad company's noted XX, earlier, Delaware. to moved on corporate domicile subsequent Curacao July approval, the to

quarter. and in our from beginning expected are effective part the long current more fully the and mix to six-point law. historically benefit by costs out certain our our reflects This there as long-term provide a including costs. simplified As reduction benefits structure improve our reduce been as rate corporate peers reduction tax non-GAAP flexibility XX% corporate to earnings of financial this third interpretations of well XX% the to has term-rate to transition, in in current expectations of changes tax These regarding incurred ability

domicile was than excited future about are change company. our budget as and U.S.-based a The under expected. earlier We completed

this activities a of end year. by are should substantially to which We the maximize efficiencies, undertaking few most be complete remaining of

to After operations for for we adjusting as the quarter per continuing reported $X.XX certain compared XX%, non-GAAP the second from net XXXX. continuing $X.XX when of rate share XXXX. the second income a operations using per was per $X.XX the XXXX, income net as long-term of for items tax share and second normalizing per GAAP For adjusted quarter same quarter from of $X.XX share, of in share

Kinetics, continuing the adjusted losses from operating per with for when operations associated income share period. was Brad the excluding mentioned, Spinal $X.XX As net

just to compensation the As last stock-based flat EPS year. expense in contributor adjusted higher versus noted, I also growth another was

over for $X.XX compensation stock-based full-year expect approximately million share. increase we to year reminder, a by or the As per $X XXXX prior

quarter, this approximately million this $X.XX. or $X.X was During

were of Moving XXXX, sales the at the second second DSOs outstanding onto XXXX. quarter or from the at the balance Days up XX the of XX days highlights. quarter sheet end days end

As noted recognition on the last call, was the primarily the this from due receivables adoption increased increase of to revenue the standard. new

XXXX. second were of of the upfront of second to This of initiatives. the when the Capital to during flat back improvement and second $XX.X $XX.X to $X million from cash times the prior consideration the quarter in lower just versus XXXX million in operating With reflects $X.X $X.X the and for cash as I at expenditures million offset Our turn quarter primarily cash the XXXX. the acquisition related $X.X inventory the improvement sets acquisition compared the increase inventory minus the the by that, instrument million million compared end impact in related it launches XXXX due noted. Cash the flow defined now the second during at period million primarily flow million the Kinetics. inflow was quarter flow to the Brad. primarily decreased the to improvements cash products. spending I the at quarter was from Spinal compared million operations for and Free end quarter to during flow equivalents as impact $XX.X quarter product prior-year year. cash of new in will The of $X.X that reflected management expenditures inventory quarter items X.X of capital decrease This year. in to to $XX.X were turns Spinal an million resulting inventory for of management the quarter was an our to the prior were investments Kinetics. was compared of end in Cash our were operations investments lower The

Brad Mason

Doug. Thanks,

ahead of $XXX million to expects foreign net the million to rates. the $XXX Looking company remainder year, on the report sales of now to current based exchange

the third million. range we to be expect in of million net now to quarter, $XXX $XXX sales For the

expectations the adjusted and in range the $X.XX of Fixation to long-term XX.X half full sales and Spinal are implant digits which year in XXXX, business reflects due Regarding spinal the each digits. now XX% spine we and earnings EBITDA from the decrease half. full XX%, Kinetics and sales. to adjusted our the share we to due XX% of RIVAL X% Extremity BioStim expect Including to per to headwinds to for grow for X% in million first shares $X.XX now and year, million currency $XX year SBU, growth million we contribution be low-single using expect the full to non-GAAP primarily the the year of in expected the to We expect fee international a now under-performance $XX range. to the of sales tax the continue Biologics in of weighted for to the for to including And reduction the mid-single XX% grow to Kinetics, lastly, one in expect launch, to rate delays growth increase the range region. for lower Spinal average the MTF to achieve second implants

$X.XX. expect EPS range the For quarter, in adjusted to be of to $X.XX we third the

giving navigate year. guidance reminder, for three last quarterly this investors we help As our numerous to quarters changes of are XXXX the the a

guidance to With questions. ready beyond, and giving in for we up However, in past. we now lines operator, will the year open the be XXXX full that, as only have we are

Operator

comes Thank Bruce SunTrust. you. line first the Nudell of from Instructions] [Operator question Our from

open. line Your is

Bruce Nudell

you’ve for congratulations Could which expectations rebranding Spinal just afternoon margin effort and on as selling a Brad, now Spinal Good kind and the of of their I'm as got you efforts sense the year kind beyond Hi. in kind long-term long-term picture including of trajectory reorganized place, a of the you've the for of unchanged, there the for that Europe, the the improvement. like sure of you paint of have and in the implication RIVAL. kind got and Ex you redomicile Kinetics well -- kind is biosimilar, a this Fix? potential Biologics team

Brad Mason

hear to Nice Bruce. from you. Absolutely,

to continues already recovered business, blip So outlook exactly No in It’s has our biosimilar, change down you're solid. QX. solid to saw there. in we a QX right. be The

there. problem no So,

We expect very the had past, expectations in same as solid. we've

year-to-date, when Regarding and spinal implants, comps doing well. pretty really last that's year. I is mean, the some on look business X.X% U.S. at you we're tough up

business. sales exactly and always and So, we're that there some improve can distributors that it expected to point. we interest, we on we're force, be, surgeons feedback we're things There’s is is terrific. things out where working Spinal be happy this interest will The the from with from U.S. at there of with track and on the getting inbound course. still Kinetics them from

of and think heading big he arms the while I spine middle – us. looking him leader to is He's FDA we in take But Tom in out year. bring get a the very timing. think to of we to out and good to for to he and experience how that. who lot great around good still we're I really a the of the he'll around and to be a his have going all what with So, knows. what has up going sales, see be the integrate going table. spine on to has get your to sales, speed international can and Still that lot that, It's relationships who little expect the we of things the come expecting also that terms Afzal point, to with a To He's world. of there, on with up, to track help next international now of

have ever which flawlessly the as in good particularly integration has spinal still gone expect. that Although as will back we're you -- can half generally regard. be that in accomplished in excited a Spinal of than then about more this we And year, we since and now implants, spot, Kinetics, challenged particularly

the fee we a until significantly. very, pleased by one in here that. reasons of we're March But ASP of of the pretty that's grew with couple MTF continue pressure while little a underperforming that's and impacted going We we’re Biologics, percent, still bit volume, X%. hit for change, from So, of split to obviously and and year. of still got very next

you It’s you Bruce, solid it's going can in -- have year, little recall, by beyond we unchanged. If before the of same recall forward. of just expect not business rebounded, going outlook take issue still had bit so here hopefully region year region for don't may is great different and ago, of couple our We a we the of that forward. going things our time, a we years have impact to region. now strongest end expectations far, That a still the next for only the but same and sort

thing as can spinal the the I I on beneficial Biologics the the businesses, The other could think The would side that. business, come business from believe relationships say realignment as benefit -- I be that and to the with BioStim side. well most our is so implant very that spine that very, of

So, it's That's then by hit business, some finally, we timing. the Extremities, cash well lumpy think can And or orders. structure. large It's business very obviously, whether whether new we're in collections pretty normal. order a it's that do

that we about there. in to worry quarter; the nothing So, saw second

and a last is what takes problem issues the RIVAL physicians a bit have RIVAL issue. us our the a We a it's couple not And dollars. a pull little couple that's distributors either. versus of will that's hesitate. the We of to different headwinds had to year have and that launched was have of guidance currency Again, caused the but on some million of only all some for components, rest it back.

going we're get and the that future. in right to So re-launch then

to $X quite I year guidance, in are be have this rest through now that the in the suffering plan the our G-Beam, about -- volume we But we feedback from for think recently drop another taken just on the guidance. fine. then think year-over-year of increased and on launched overall we that -- out Charcot mean, drivers foot and QX product But order a to one which is bit of from add the in our us having remainder our business for portfolio. sales you move great the -- year, our we there. core great we’ll primary for the of the We're by of it. our will X.X%. million getting of see which business, When we of that's did I gives

So, businesses are all that's kind of the expectations. of overview drivers what our and the the and of

Bruce Nudell

And put to correct mouth I'm going words for your just my Thanks. and follow-up, in me.

around thinking ranges just So be X% about about Kinetics thinking kind know midterm X%. at with I those X% to for X% to BioStim also of the X% you be reasonable trajectories? with to then should but year, thinking this beyond Fix, Spinal turbulence this spine to of X%, Are Biologics and maybe Ex

Brad Mason

that. on should think of think spine it would Spinal Kinetics, I better than I in be Spinal with the I With that's Kinetics. in I more BioStim, hopeful right. that than reasonable couple spot And higher downside. potential you're maybe a be on then Extremity that’s would hope. Fixation, I there, points opportunity. Probably, some of would say, estimate, upside probably higher a

Bruce Nudell

Thanks so great a much. Have day.

Brad Mason

Okay.

You bet, Bruce. Thank you.

Operator

you. Thank

comes question the next from of Our line from Denhoy Jefferies. Raj

Your line is open.

Raj Denhoy

Hi. afternoon. Good

Brad Mason

Hey, Raj.

Raj Denhoy

is like a everything. us Bruce. lot excluding But of in question in sounds it's was of there gave that the growth slowest you X.X% quite posted underlying one-time bit have last question kind growth in the guys parts a of information of time, a That moving So, the issues though guess lot I from you the quarter.

more that the some of how through the confidence might the we've might quarter? we in in that As of contained these do into there the about orders get with third been timing we quarter of this or distributors issues perhaps behind anything on sort seen that else think going fourth, the be isn't have -- anything softness

Doug Rice

Sure, Raj.

million. at piece So, that exceeded order our Fixation end open BioStim I open probably of had important totals the orders Extremity we normal the here most $X.X period the our business, think is of in and our

we had guidance that, versus $XXX,XXX. a also add you currency So our headwind of

those end of two we're and You QX. put in range the our top at together

expected while business already our in -- there the BioStim So, Extremities we recovered, recover as has well. that to

talked forecasting Although a little few going be our I any can reasons. of can sort have more will more a use softness that I'm and underperforming for happened we a hit, in for some are about, our business in reason very, choppy. a And XXXX orders a that, I QX benchmark changes little than going and view for it not beyond. businesses business the it is an a about other would Other or period make biologics very have some you, in of anomaly we that, have tell that's Extremities because this core little solid. our quarter be sales bit. cautious as -- international that’s we to we RIVAL It's forward. nothing the underlying spine those than our a our issue large business

Raj Denhoy

But decision just Okay. the a I’m be product? delay launch I with explanation. couple not of the missed so behind if sorry gave the you us that to Maybe or what's follow aggressive if it, the – ups, RIVAL product more

Brad Mason

on it we failures two disproportionate issue were hasn’t about a components couple system. components that of almost physicians of you And distributors. an But Yeah. hesitate X,XXX had SKUs in that These people overall had a do that the it in and the – few we – when out a I components pulled field of also impact the some who mean, back. We had system that, gets had the -- system. has a using the a

anything the estimating have speak that we are portion going to the relaunched have of to in end between and we're we confidence year. it. the not sales still we’re we're and number -- sales line, and now year-end, the SKUs fix not in But attitude a the We're we it, that by a new significant then, the of new components pushing low. to of a of And So while hope system. selling fixed with those

Raj Denhoy

there recognition last I quarter the or resulted ask last this some There that than some that recognition might second perhaps recognize whether XXX of sooner just questions and delayed was in whether in in standard revenue it actually in have the for Maybe revenue would were perhaps normally? to standard? can want some you you would if there have the that revenue maybe been maybe additional quarter question. have around recognition quarter that comment not fallen a sense in ASC Okay. first sense quarter Is you about anything accounting the that one front,

Doug Rice

revenue Yeah. is question. expect generally the recognition ASC up revenue new say to would Raj, would the with Yeah. match XXX I that’s recognition previous we that standard. time over a Doug. good under This

mentioned, just to Brad extremities or choppy. our does tend lumpy As be business

volatility, as so was noted. you there And QX some

over think, I even time, will out. that that

fact, In other going way of the we it direction. the terms other in saw in QX worked

Raj Denhoy

Okay.

perhaps of we it you out? take the get a again expect year explaining these spikes when is perhaps see to quarter in we're will And reporting some that entire where and do full So volatility won't the more seeing. we quarter normalized before

Doug Rice

Yeah.

to start will behind get more we think it quarter every us, an basis. I accumulated on normalize that

Raj Denhoy

leave it I'll enough. Fair there. Thanks. Okay.

Brad Mason

Yeah. Raj. Thanks,

Operator

Thank you.

from Bijou comes from question Cantor next Fitzgerald. Our Craig

Your open. line is

Craig Bijou

Good taking afternoon, for questions. guys. the Thanks

Brad Mason

Craig. Sure,

Craig Bijou

recognize guys EPS I So obviously at I $X.XX start by it to raised midpoint. the you wanted guidance. with

You’ve beaten QX $X.XX. by

half correct, I spending about at talked I'm think what back in to year, least or – were the was the there R&D increased we relative if believe I expecting. maybe of you

– the XX from down also a tax, tax moving get but benefit were you to to from So, and XX. going

you $X.XX. raised if by guys but you’ve and talk just takes it maybe about the since you So by beaten puts only $X.XX could QX

for EPS the on takes half. and puts back the maybe the So line

Brad Mason

sure, Yeah, Craig.

So, probably around a tax likely on as most have of we're $X.XX. the pickup going to line

And struggle That's little so, maybe – where sales essentially of our a half current bit well-covered a that about in make guidance. it The shortfall where we’ll is in about that, put we're more. our into thinking little bit. our we to guidance sure have we're

I think by we're in reduction million the benefit. going EPS that feel in $X the that tax that offset with to sales,

Craig Bijou

half, And X.X% guys Okay. the year-to-date. if said ask the That's on spine you're helpful. I first U.S. could strong Obviously, business. you in

expecting of was know baked in in the for into in of number back the are or spine X.X% business so. your this, what's guidance second the the kind half the think but year? quarter play And what comps U.S. I you I

Doug Rice

in $X.X But probably of that through way year. be spine. days about half It in bit. to Hopefully inventory second expecting the XX some the Yeah. field, the That's getting back we’ve challenged next work would enough or to going challenges international new in – We're we're so. a be into holding expecting even we're little that so going products our is the still on the us bit million in which we're or little better. got headwind actually the a

that rate XX% looking we’re XX% the $X growth in I you we’ve in if Spinal still talked QX. think in, it Kinetics million being there. of the to will So factor at million Spinal Kinetics $X included And of was $X.X with which million, in about all to

just So there. then, from then, it's with arithmetic

Craig Bijou

Yes.

Doug Rice

that the to that. with you call. do happy after I’m help can We

Craig Bijou

it. quantify script. if could from I that? any that mark missed the could if can I Got [ph] re-domiciling in, and there last Sorry, is from One one it the you Perfect. you squeeze operating

Brad Mason

Yeah.

there. haven’t We any savings quantified

will the but side, think some save there. of more side probably time. – over sorts tax little nothing things And money those and they I on but come over quantified we’ve maybe we'll on bit and that a the time, there's soft legal

happy be just U.S. to We’re the in

Craig Bijou

for Thanks the great. guys. taking questions, Okay,

Brad Mason

Great. Thank you.

Operator

you. Thank

Ladenburg from question Jeffrey comes from next Thalmann. Our Cohen

open. Your line is

Jeffrey Cohen

Thanks for taking the questions.

Brad Mason

Jeff. Hey,

Jeffrey Cohen

year? you or something could spillover in quarter about little talk back it’s So the bullish normalized third the to a the ordering in of quarter, going the patterns some to of the and expect half third more bit a the see you on bit into be Stim of that

Brad Mason

thought We’ve it. We already July. seen

So we already. in saw whatever July orders that high, were carried was returned over that the that – unusually open unusually

have it process out late minimize put field open we and good approved believe we once period think to get July signatures prescriptions of some the not, also holiday-related, assignment of on some documentation medical a They of have necessity, got into medical to that, like method device. to have toward – that or we is help calls back don't, early holiday I – we've coming just shape. sales – be helps of benefits, was the on get now -- the will the the things it again, Xth for of don't making more that thing that a order order, We’ve they but holiday. period. a we that So people we’re we bit in I have each came all part culturally, in note then end push into – – little and Jeff letters just apply an the it The have the of one that agents sales. that is But was believe for future. But don't But orders. and in had in insurance the a go to a authorization, – I that in. important ends And left at team will lot to that's

a I can I habit bad to happen. into. to that It think get employees create conflict it's don't want for have

with beyond try we compliance to we from sense but a practice good So, each not some it's that close standpoint. a of urgency, period don't push because

Jeffrey Cohen

ordering of side, on the Got about your correlated it. And also Extremity patterns well? some comments are your comments as

Brad Mason

a little bit Ordering different. patterns for are Extremities

is very that earlier expecting last We come the that business business June. I’ll had the the percentage, of large around stocking large ship. a or of say, couple We have that in that are orders few in we of distributors couldn't a significant of didn't world. days quarter It such a percentage we

about in just a it, want any quarter. to that's choppier little that business. go something cautious out business So, July. I that because happen and bit It's will could predicting But those in be

of kind a be look just expect you just -- to But coincidence would it remove that and really never it on if will we're some that a I choppiness. in basis don't if but could it pattern, happen know. at business of the than to again, So, longer that have term QX, happens rather

probably for we're little that side in the the conservative on business a estimates year. the between now So bit end and of our

Jeffrey Cohen

a looks further a in on the it. balance feel and year little going Could Okay. as the the ASPs, there what's give that well? clarity you the how Got as for you far as on Biologics you little into give and can reduction read how us us of business

Brad Mason

talked I territories there. Biologics, don't rebound lot rebound the don't of Sure. expect still a in one year. that We’ll – of we’re about. think struggling I this I

which with it take of have will But MTF. out I've -- X% think erred past, grow time. hope come increase expect. in We will that I've – franchise our and I year. in and quicker I so net I case did volume our in you if more the the be than next things in beginning this Trinity was then ASP volume pressure X% X% be

MTF if better the a bit split change. increase We're the was net change – around is X% X% is ASP usually actually typical. Our out take little That you range. ASP than

to trajectory the by should should So see with the mentioned few long years. realignment from last seen that. we're we we back next I happy term, in of And as that we on the the I think have And the benefit spine before, units. year, be rest

Jeffrey Cohen

about Kinetics? all the And little line? Is related expense contents Spinal Perfect. you lastly, then bit income I may. to comment million, a Okay. that could of Doug, other if the the $X.X

Doug Rice

No.

of it. Some

to it. re-measurement notes That's foreign related perspective. a from currency intercompany is of of it the of non-cash Some certain majority

Jeffrey Cohen

out Is the broken within press that release?

Brad Mason

not. is It

Jeffrey Cohen

Okay.

questions. taking Guys, Perfect. thanks for Okay. the

Brad Mason

Jeff. Thanks,

Operator

Thank you.

Sidoti the with Company. from & comes line question Jim last of Sidoti Our

Your line is open.

Jim Sidoti

afternoon. hear Good you me? Can

Brad Mason

Jim. Yeah,

Doug Rice

Hi, Jim.

Jim Sidoti

afternoon. Hey. Good

and top $X So how it million you line issues. Of and down the bucket? you is about in about put the took buckets? you $X of change that just timing of some in distribution talked much Can each in million, kind

Brad Mason

Absolutely.

if $X.X about now can of the we year, we're last million seeing we million guidance. So we because shortfall the $X currency thinking of RIVAL the of Biologics what there, talked about. estimated headwind were million about $X for guidance expectation rest think about the gave you region QX, million end in from you shortfall put to in to of about change QX a that the Spine, what same $X.X at when the of And about QX was short the about International our

are. So buckets about for the where million that'll total that's $X

Jim Sidoti

distributors? were Is the you new back business and Okay. said I the the with that it up? just you territory? with it force the been And new to territory. down got it. Biologics How another is through you've familiar think direct the sales past Is teams What business? this key with getting getting their in do

Brad Mason

opportunity, had a management. sales sales area. not that in We He manager in our us good different very it's space, left a in Yeah, for regional place.

huge, so, And have and it the for territory. When will. people huge three that covering had the leadership saw yet reorganizing two expect We've found been Northeast, we've it and difference, we we as right make not in that we territories a do, then. can since we

our the realignment now businesses, sales or So that, spine across can of reorganization of – well. as of of help business the all spine team businesses management the with marketing that coupled breadth just getting and more

all is that, think is that well our as from again, as particularly we but haven't our position have with both biologics one best that there's and that there, arms said got risk we the as benefit BioStim completely the to probably physicians in with I relationships I exist distributors. repeating around with of myself the at a opportunities earlier, So lot. And the in business

Jim Sidoti

to any still were event? then changes for late think XXXX Kinetics And Okay. the Spinal timeline there You approval? a that's the

Brad Mason

XXXX good. -- still looks still We’re

or good months – still It before plus middle year, be I six target, be a I months middle the of is months six that three months sort still could of think But It is that. could guess after July minus. time before frame. before. or of that XXXX. best three that's could It Our think be

Jim Sidoti

person, one Okay. EPS, – is out? in other $X.X the forma that out just last to that – included follow-up the And that breaking a is me, your charge for that then last in million or pro broken income,

Brad Mason

No. That's Jim. out, adjusted

Jim Sidoti

was What that? for? was what again, And Okay. that

Brad Mason

that It's re-measurement currencies. different notes mostly intercompany in are of

broken the consideration There's item separate marked that accounting contingent that around just consideration out line the we've a the through Spinal contingent in on it's re-measurement. value adjustment and So bit as purchase to done some that around of the of that's other we we that little Kinetics, have have table. a income fair

Jim Sidoti

Okay. All you. Thank right.

Brad Mason

Thanks, care. Jim. Take

Operator

showing no Mason for conference questions. Mr. the Brad Thank I remarks. back turn to closing to I'm you. further would like

Brad Mason

you the us good for I joining talking the questions. to operator, evening. Thank to it. you, today I good appreciate thanks, look a near very And and in everyone, forward and Have future.

Operator

program. you and does for thank gentlemen, participating in today's conclude This Ladies conference. the

Everybody great disconnect. all have a may day. You

Orthofix Medical (OFIX) 6 Aug 182018 Q2 Earnings call transcript